Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinomenine for primary membranous nephropathy
ChiCTR2100047996Phase 4Not yet recruiting
- Sponsor
- Macau University of Science and Technology
- Start
- Jul 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sinomenine in idiopathic membranous glomerulonephritis (IMG) (2 arms), sponsored by Macau University of Science and Technology. Primary endpoints: 24-hour urine protein quantitation, Serum albumin and 2 more. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
sinomenine
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on ChiCTR2100047996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047996.